IFNG and neoplasm: We propose a sequential model in which (i) ATO induces ROS accumulation within tumor cells and upregulates HLA-I expression, (ii) subsequently promotes TCR-T recognition and IFN-γ release, (iii) ultimately triggers and reinforces IFN-γ-mediated ferroptotic cell death.